Seasonal allergic rhinitis: fluticasone propionate and fluticasone fur
Links shared publicly online about this topic.
- 960total visits
Seasonal allergic rhinitis: fluticasone propionate and fluticasone fur
View full resource at dovepress.com
Tags: Allergies, Seasonal Allergy, Asthma Medication, COPD Medication, Flovent, Flixotide, Flonase, Flixonase
Most Recently Shared on August 9, 2010 at 7:31 pm By:
Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated. http://bit.ly/cHQidU
Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
crd.york.ac.uk — “Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness” View full resource at crd.york.ac.uk
Most Recently Shared on September 7, 2011 at 12:40 pm By:
Similar efficacy between fluticasone propionate and fluticasone furoate in seasonal allergic rhinitis http://t.co/1c6LQcM
Meda: Dymista filed with the FDA | Business Wire
businesswire.com — “Regulatory News A New Drug Application for a novel formulation of azelastine hydrochloride and fluticasone propionate, tentatively named “Dymist” View full resource at businesswire.com
Most Recently Shared on April 4, 2011 at 12:59 pm By:
Dymista (combination of fluticasone propionate/azelastine) filed with the FDA for seasonal allergic rhinitis by Meda - http://goo.gl/600KE
MEDA submits Dymista NDA to FDA for seasonal allergic rhinitis treatment
news-medical.net — “A New Drug Application for a novel formulation of azelastine hydrochloride and fluticasone propionate, tentatively named "Dymista", has been submitted to the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on April 4, 2011 at 7:22 am By:
MEDA submits Dymista NDA to FDA for seasonal allergic rhinitis treatment: A New Drug Application for a novel for... http://bit.ly/fT4LRA
Meda: Positive Study Results Presented For Dymista
medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patie” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 12:05 pm By:
Meda: Positive Study Results Presented For Dymista http://mnt.to/3SCB #entnews
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - MPR
empr.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis” View full resource at empr.com
Most Recently Shared on March 22, 2011 at 6:08 pm By:
MPR News: Phase 3 Study of Dymista for Seasonal Allergic Rhinitis: Meda announced positive results from its Phas... http://bit.ly/hpduGL
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - ONA
oncologynurseadvisor.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitis” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 22, 2011 at 6:07 pm By:
Phase 3 Study of Dymista for Seasonal Allergic Rhinitis http://goo.gl/fb/yp3o2
Allergy/Imm Medical News about Asthma
mdlinx.com — “Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 12:51 pm By:
Allergy/Immunology Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal alle... http://bit.ly/dwzfcF
ENT Medical News about Asthma
mdlinx.com — “Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 11:31 am By:
ENT: Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis:... http://bit.ly/br3hMc
Advertisement

